Literature DB >> 33845131

Chromatin accessibility in neuropsychiatric disorders.

Gabor Egervari1.   

Abstract

Epigenetic mechanisms have recently emerged as critical regulators of brain function in health and disease. By controlling the accessibility and the expression of specific genes, these pathways can mediate transient and long-lasting changes in neuronal function in both physiological and pathological contexts. Due to the extreme complexity of the epigenetic regulatory landscape, emerging methods that directly assay chromatin accessibility are of particular interest. Here, I review recent insights gained on open and closed chromatin states in the brain, with emphasis on neuropsychiatric disorders. These advances generated an invaluable wealth of information that can help us better understand gene regulation in the brain and its impairments that contribute to the development of disease.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain; Chromatin accessibility; Neuropsychiatric disease

Mesh:

Substances:

Year:  2021        PMID: 33845131      PMCID: PMC8169633          DOI: 10.1016/j.nlm.2021.107438

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  57 in total

1.  Getting pharmaceutical R&D back on target.

Authors:  Mark E Bunnage
Journal:  Nat Chem Biol       Date:  2011-06       Impact factor: 15.040

2.  Single-nucleus analysis of accessible chromatin in developing mouse forebrain reveals cell-type-specific transcriptional regulation.

Authors:  Sebastian Preissl; Rongxin Fang; Hui Huang; Yuan Zhao; Ramya Raviram; David U Gorkin; Yanxiao Zhang; Brandon C Sos; Veena Afzal; Diane E Dickel; Samantha Kuan; Axel Visel; Len A Pennacchio; Kun Zhang; Bing Ren
Journal:  Nat Neurosci       Date:  2018-02-12       Impact factor: 24.884

3.  The Dynamic Landscape of Open Chromatin during Human Cortical Neurogenesis.

Authors:  Luis de la Torre-Ubieta; Jason L Stein; Hyejung Won; Carli K Opland; Dan Liang; Daning Lu; Daniel H Geschwind
Journal:  Cell       Date:  2018-01-04       Impact factor: 41.582

4.  HiChIP: efficient and sensitive analysis of protein-directed genome architecture.

Authors:  Maxwell R Mumbach; Adam J Rubin; Ryan A Flynn; Chao Dai; Paul A Khavari; William J Greenleaf; Howard Y Chang
Journal:  Nat Methods       Date:  2016-09-19       Impact factor: 28.547

5.  Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position.

Authors:  Jason D Buenrostro; Paul G Giresi; Lisa C Zaba; Howard Y Chang; William J Greenleaf
Journal:  Nat Methods       Date:  2013-10-06       Impact factor: 28.547

6.  Comprehensive mapping of long-range interactions reveals folding principles of the human genome.

Authors:  Erez Lieberman-Aiden; Nynke L van Berkum; Louise Williams; Maxim Imakaev; Tobias Ragoczy; Agnes Telling; Ido Amit; Bryan R Lajoie; Peter J Sabo; Michael O Dorschner; Richard Sandstrom; Bradley Bernstein; M A Bender; Mark Groudine; Andreas Gnirke; John Stamatoyannopoulos; Leonid A Mirny; Eric S Lander; Job Dekker
Journal:  Science       Date:  2009-10-09       Impact factor: 47.728

Review 7.  Epigenetic mechanisms of drug addiction.

Authors:  Eric J Nestler
Journal:  Neuropharmacology       Date:  2013-04-30       Impact factor: 5.250

8.  Neuronal activity modifies the chromatin accessibility landscape in the adult brain.

Authors:  Yijing Su; Jaehoon Shin; Chun Zhong; Sabrina Wang; Prith Roychowdhury; Jongseuk Lim; David Kim; Guo-Li Ming; Hongjun Song
Journal:  Nat Neurosci       Date:  2017-02-06       Impact factor: 24.884

9.  Expanded encyclopaedias of DNA elements in the human and mouse genomes.

Authors:  Jill E Moore; Michael J Purcaro; Henry E Pratt; Charles B Epstein; Noam Shoresh; Jessika Adrian; Trupti Kawli; Carrie A Davis; Alexander Dobin; Rajinder Kaul; Jessica Halow; Eric L Van Nostrand; Peter Freese; David U Gorkin; Yin Shen; Yupeng He; Mark Mackiewicz; Florencia Pauli-Behn; Brian A Williams; Ali Mortazavi; Cheryl A Keller; Xiao-Ou Zhang; Shaimae I Elhajjajy; Jack Huey; Diane E Dickel; Valentina Snetkova; Xintao Wei; Xiaofeng Wang; Juan Carlos Rivera-Mulia; Joel Rozowsky; Jing Zhang; Surya B Chhetri; Jialing Zhang; Alec Victorsen; Kevin P White; Axel Visel; Gene W Yeo; Christopher B Burge; Eric Lécuyer; David M Gilbert; Job Dekker; John Rinn; Eric M Mendenhall; Joseph R Ecker; Manolis Kellis; Robert J Klein; William S Noble; Anshul Kundaje; Roderic Guigó; Peggy J Farnham; J Michael Cherry; Richard M Myers; Bing Ren; Brenton R Graveley; Mark B Gerstein; Len A Pennacchio; Michael P Snyder; Bradley E Bernstein; Barbara Wold; Ross C Hardison; Thomas R Gingeras; John A Stamatoyannopoulos; Zhiping Weng
Journal:  Nature       Date:  2020-07-29       Impact factor: 69.504

10.  Chromatin accessibility mapping of the striatum identifies tyrosine kinase FYN as a therapeutic target for heroin use disorder.

Authors:  Gabor Egervari; Diana Akpoyibo; Tanni Rahman; John F Fullard; James E Callens; Joseph A Landry; Annie Ly; Xianxiao Zhou; Noël Warren; Mads E Hauberg; Gabriel Hoffman; Randy Ellis; Jacqueline-Marie N Ferland; Michael L Miller; Eva Keller; Bin Zhang; Panos Roussos; Yasmin L Hurd
Journal:  Nat Commun       Date:  2020-09-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.